𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective?

✍ Scribed by Gin-Ho Lo

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
44 KB
Volume
50
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreating chronic hepatitis C with dail
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results
✍ Bruce R. Bacon; Mitchell L. Shiffman; Flavia Mendes; Reem Ghalib; Tarek Hassanei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

Up to 50% of patients with chronic hepatitis C fail to respond to initial therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV). With unsuccessful viral eradication, these patients remain at risk for developing progression of their liver disease. Retreatment with PEG-IFN/RBV yields sustain

Neutralizing antibodies to interferon-α
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy*)
✍ Philippe Halfon; Sophie Pérusat; Marc Bourlière; Jean-Pierre Bronowicki; Pascale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract A lack of antiviral response in patients with chronic hepatitis C treated with pegylated (PEG)‐interferon (IFN)‐α‐2a + ribavirin (RIBA) may be explained by neutralizing antibodies to IFN‐α‐2a. The aim of this study was to assess neutralizing antibodies to IFN‐α‐2a and IFN levels in non‐

Hepatitis C treatment in “difficult-to-t
Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat